PlainRecalls
FDA Drug Moderate Class II Terminated

Westminster Irbesartan Tablets, USP 300 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 Manufactured for: Westminster Pharmaceuticals, LLC. Olive Branch, MS 38654 a) 30 count bottle NDC 69367-121-01; b) 90 count bottle NDC 69367-121-03

Reported: December 19, 2018 Initiated: October 29, 2018 #D-0302-2019

Product Description

Westminster Irbesartan Tablets, USP 300 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 Manufactured for: Westminster Pharmaceuticals, LLC. Olive Branch, MS 38654 a) 30 count bottle NDC 69367-121-01; b) 90 count bottle NDC 69367-121-03

Reason for Recall

CGMP Deviations: FDA laboratory testing confirmed traces of NDEA impurity in specific lots of Irbesartan.

Details

Units Affected
3976 bottles
Distribution
Nationwide.
Location
Olive Branch, MS

Frequently Asked Questions

What product was recalled?
Westminster Irbesartan Tablets, USP 300 mg Rx Only Manufactured by: ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 Manufactured for: Westminster Pharmaceuticals, LLC. Olive Branch, MS 38654 a) 30 count bottle NDC 69367-121-01; b) 90 count bottle NDC 69367-121-03. Recalled by Westminster Pharmaceuticals Llc. Units affected: 3976 bottles.
Why was this product recalled?
CGMP Deviations: FDA laboratory testing confirmed traces of NDEA impurity in specific lots of Irbesartan.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 19, 2018. Severity: Moderate. Recall number: D-0302-2019.